1 octobre 2025|
AI
|2 months agoUS Pharma Tariffs Could Push Switzerland Toward Recession
Economists warn of recession risk as US threatens 100% tariffs on Swiss pharmaceutical exports
AI
Generated IllustrationKey Takeaways
AI
- US President Donald Trump has threatened 100% tariffs on branded or patented pharmaceutical products starting October 1.
- Tariffs can be avoided if companies build pharmaceutical factories within the United States.
- Roche and Novartis announced major investments in new US plants in April.
- Novartis is launching a platform to sell Cosentyx directly to US patients at a discount.
By The Numbers
100%
Tariff rate
7-8%
GDP Contribution
0.3% to 0.6%
GDP Impact
39%
Previous Tariff Rate
They Said
"If a large proportion of exports to the United States in the pharmaceutical sector were to be subject to tariffs... there would be a clear risk of recession in Switzerland."
"Large companies such as Roche and Novartis could be exempt, but many smaller companies will be affected."
1
The Recession Ultimatum
2
Pharma: The Engine Stalls
3
The 'Build in America' Mandate
4
Compounding Economic Shocks
5